RAC 1.32% $1.87 race oncology ltd

There is nothing fundamentally wrong with MST Access’s report,...

  1. 2,585 Posts.
    lightbulb Created with Sketch. 9817
    There is nothing fundamentally wrong with MST Access’s report, it is just very, very conservative in how it values Bisantrene and the FTO opportunity in particular. It is a great place to start any research, but I you really need to do your own research.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.87
Change
-0.025(1.32%)
Mkt cap ! $317.5M
Open High Low Value Volume
$1.97 $2.02 $1.85 $1.189M 605.4K

Buyers (Bids)

No. Vol. Price($)
1 200 $1.86
 

Sellers (Offers)

Price($) Vol. No.
$1.89 30 1
View Market Depth
Last trade - 16.10pm 13/06/2024 (20 minute delay) ?
Last
$1.86
  Change
-0.025 ( 1.00 %)
Open High Low Volume
$1.97 $2.04 $1.86 48029
Last updated 15.57pm 13/06/2024 ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.